Results
Akums FY26 Revenue Rises 5.9%, EBITDA 13%
Akums Drugs & Pharmaceuticals reported FY26 operating revenue of Rs 4,359 cr, up 5.9% YoY, and Adj EBITDA of Rs 522 cr, up 13.3%.
Q4 FY26 revenue reached Rs 1,158 cr (+9.7% YoY) with Adj EBITDA margin
